Files
Download Full Text (467 KB)
Contents
- Managing Chemotherapy-Induced Neuropathy: Neuromodulation, pharmacological treatments show promise against peripheral neuropathy in cancer patients.
- Treating Tobacco Addiction: MD Anderson provides pharmacotherapy, counseling to help smokers quit plus cessation education, resources for community practitioners
- HOUSE CALL: Smoking-Related Cancers- Cancer risks from tobacco are not limited to the lungs, but quitting reduces these risks
Publication Date
11-1-2017
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Kavelaars, Annemieke; Prinsloo, Sarah; Abdi, Salahadin; Karam-Hage, Maher; Ribius, Vance; Blalock, Jan; Beneventi, Diane; Witmer, Leann; Frerking, Janeene; Antwi, Andrea; Hurst, Alex; Evans, Mark; Wippold, Rosario; Ma, Jiacheng; Cinciripini, Paul; Peripheral Nervous System Diseases; Antineoplastic Agents; Drug Therapy; Neurotransmitter Agents; Tobacco Use Disorder; Tobacco Use Cessation; Smoking Cessation; Nicotine Replacement Therapy; Tobacco Use Cessation Devices; Tobacco Smoke Pollution; Lung Neoplasms; Neoplasms.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Munch, Joe and Tutt, Bryan, "OncoLog, Volume 62, Number 11-12, November - December 2017" (2017). OncoLog MD Anderson's Report to Physicians (All issues). 285.
https://openworks.mdanderson.org/oncolog/285
Conditions Governing Access
Redacted
